amlodipine has been researched along with cytochrome c-t in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, JX; Ju, RJ; Li, N; Li, RJ; Lu, WL; Men, Y; Tian, W; Wang, XX; Yao, HJ; Ying, X; Yu, Y; Zhang, L; Zhang, Y; Zhou, J | 1 |
1 other study(ies) available for amlodipine and cytochrome c-t
Article | Year |
---|---|
Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancer.
Topics: Amlodipine; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Daunorubicin; Drug Carriers; Drug Resistance, Neoplasm; Female; Humans; In Situ Nick-End Labeling; Liposomes; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria | 2011 |